Second Generation DICART Prototype Validation (DICART II)

Civil Hospices of Lyon

Status: Completed

Conditions: Acute Circulatory Failure; Shock

Treatments: Diagnostic Test: Clinical measurement of capillary refill time; Device: Standardized measurement of capillary refill time by second generation DICART prototype

Study type: Interventional

Funder types: Other

Identifiers

NCT05847998

2021-A02595-36 (Other Identifier)

69HCL21_0635

Details and patient eligibility

About

Capillary refill time (CRT) is a clinical sign for diagnosis of acute circulatory failure and response to treatment but is also associated with prognosis in patient with shock.

CRT is clinically evaluated by physician with a high risk of inter and intra evaluator variations, depending, for example, on measurement site, pressure applicated or visual evaluation.

The investigator hypothesizes that CRT measurement with second generation DICART prototype will be well correlated with clinical measurement.

Enrollment: 25 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

->18 years old

• Acute circulatory failure
• Written informed consent given by patient or its relatives

Exclusion criteria

• Pregnant women, breastfeeding women, childbearing age women without oral contraception
• Cutaneous lesion at measurement site
• Patient under legal protection
• Patient already included in another interventional clinical trial

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

25 participants in 1 patient group

measurement of capillary refill time

Experimental group

Description:

measurement in a cohort of ICU adult patients with acute circulatory failure

Treatment:

Device: Standardized measurement of capillary refill time by second generation DICART prototype

Diagnostic Test: Clinical measurement of capillary refill time